These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10518245)

  • 1. Kinetic release of theophylline from hydrophilic swellable matrices.
    Vargas CI; Ghaly ES
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1045-50. PubMed ID: 10518245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
    Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
    Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of binary polymer system in drug release rate modulation. 2. Influence of formulation variables and hydrodynamic conditions on release kinetics.
    Kim H; Fassihi R
    J Pharm Sci; 1997 Mar; 86(3):323-8. PubMed ID: 9050800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN; Schnaare RL; Sugita ET; Schwartz JB
    Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of theophylline matrices using xyloglucan.
    Badillo N; Ghaly ES
    Pharm Dev Technol; 2008; 13(6):481-6. PubMed ID: 18720251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of agitation sequence and ionic strength on in vitro drug release from hypromellose (E4M and K4M) ER matrices--the use of the USP III apparatus.
    Asare-Addo K; Kaialy W; Levina M; Rajabi-Siahboomi A; Ghori MU; Supuk E; Laity PR; Conway BR; Nokhodchi A
    Colloids Surf B Biointerfaces; 2013 Apr; 104():54-60. PubMed ID: 23298588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug release from Carbomer 934 matrices.
    Russo LI; Ghaly ES
    P R Health Sci J; 2000 Jun; 19(2):131-7. PubMed ID: 10909708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.
    Williams RO; Sykora MA; Mahaguna V
    AAPS PharmSciTech; 2001 Jun; 2(2):E8. PubMed ID: 14727883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers. II. Effect of HPMC with different degrees of methoxy/hydroxypropyl substitution.
    Escudero JJ; Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2010 Mar; 387(1-2):56-64. PubMed ID: 19969052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of nifedipine controlled release tablets prepared using mucoadhesive swellable polymer.
    Felician WA; Ghaly ES
    Pharm Dev Technol; 2011 Oct; 16(5):536-41. PubMed ID: 20954856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of hydroxypropyl methylcellulose donut-shaped tablets.
    Cheng K; Zhu J; Song X; Sun L; Zhang J
    Drug Dev Ind Pharm; 1999 Sep; 25(9):1067-71. PubMed ID: 10518248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral sustained-release bioadhesive tablet formulation of didanosine.
    Betageri GV; Deshmukh DV; Gupta RB
    Drug Dev Ind Pharm; 2001 Feb; 27(2):129-36. PubMed ID: 11266224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular weight polyethylene oxides (PEOs) as an alternative to HPMC in controlled release dosage forms.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 2000 Feb; 195(1-2):229-38. PubMed ID: 10675700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and release characteristics of hydroxypropyl methylcellulose matrix tablet containing melatonin.
    Lee BJ; Ryu SG; Cui JH
    Drug Dev Ind Pharm; 1999 Apr; 25(4):493-501. PubMed ID: 10194604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the influence of mean HPMC particle size and number of polymer particles on the release of aspirin from swellable hydrophilic matrix tablets.
    Heng PW; Chan LW; Easterbrook MG; Li X
    J Control Release; 2001 Sep; 76(1-2):39-49. PubMed ID: 11532311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrices of water-soluble drug using natural polymer and direct compression method.
    Rosario NL; Ghaly ES
    Drug Dev Ind Pharm; 2002 Sep; 28(8):975-88. PubMed ID: 12378966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of drug release from HPMC matrices: effect of physicochemical properties of drug and polymer concentration.
    Fu XC; Wang GP; Liang WQ; Chow MS
    J Control Release; 2004 Mar; 95(2):209-16. PubMed ID: 14980769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of polymer content on early gel-layer formation in HPMC matrices: The use of CLSM visualisation to identify the percolation threshold.
    Mason LM; Campiñez MD; Pygall SR; Burley JC; Gupta P; Storey DE; Caraballo I; Melia CD
    Eur J Pharm Biopharm; 2015 Aug; 94():485-92. PubMed ID: 26143369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.